XTalks

JANUARY 17, 2024

Oncology is recognized as having the largest drug pipeline of any therapeutic area. Estimates based on publicly available information suggest more than 40 percent of all new therapies in development are cancer treatments. Dr. Morrison and Dr. Vidal shared their insights from the 2023 ESMO conference which occurred in Madrid.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Gene Therapy 124

XTalks

JANUARY 16, 2024

There are other challenges facing CNS drug development, for example, higher-than-average patient drop-out rates due to the burden associated with attending clinical site visits. Barnum articulates a core issue: the variability in a patient’s condition.

Development 122

Development Drugs Clinical Trials Clinical Trials 122

Drug Discovery World

DECEMBER 26, 2023

Through this collaboration with Ionis, if regulatory approval is received, we look forward to bringing donidalorsen to patients in Europe to address the unmet medical needs of patients with HAE.” This agreement is aligned with our strategy to initially focus our commercialisation efforts on the US market.

Drugs 52

Drugs Development Medicine Bioinformatics 52

Pharma Marketing Network

APRIL 30, 2021

Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52